REFERENCES
- Eiberg H, Berendt I, Mohr J. Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nature Genet 1995; 10: 354–6.
- Hellström AL, Hanson E, Hansson S, Hjälmas K, Jodal U. Micturitions habits and continence in 7 year old Swedish school entrants. Eur J Pediatr 1990; 149: 434–7.
- Mark SD, Frank JD. Nocturnal enuresis. Br J Urol 1995; 75: 427–34.
- Shelov SP, Gundy J, Weiss JC, et al. Enuresis: a contrast of attitudes of parents and physicians. Pediatrics 1981; 67: 707–10.
- Graziottin A, Chiozza ML. Nocturnal enuresis: social aspects and treatment perspectives in Italy. Scand J Urol Nephrol 1994; 163: 21–7.
- Moffat MEK, Kato C, Pless IB. Improvements in self-concept after treatment of nocturnal enuresis: a rando-mized clinical trial. J Pediatr 1987; 110: 647–52.
- Moffat MEK. Nocturnal enuresis: psychological im-plications of treatment and non-treatment. J Pediatr 1989; 114: 697–704.
- Schulpen TWJ. The burden of nocturnal enuresis. Acta Paediatr 1997; 86: 981–4.
- Hagglof B, André]) O, Bergstrom E, Marklund L, Wendelins M. Self-esteem before and after treatment in children with nocturnal enuresis and urinary incon-tinence. Scand J Urol Nephrol 1996; 79: 82.
- Forsythe WI, Butler RJ. Fifty years of enuretic alarms. Arch Dis Child 1989; 64: 879–85.
- Fritz GK, Rockney RM, Yeung AS. Plasma levels and efficacy of imipramine treatment for enuresis. J Am Acad Child Adolesc Psychiatry 1994; 33: 60–4.
- Cronin AJ, Khalil R, Little TM. Poisoning with tricyclic antidepressives: an avoidable cause of childhood deaths. Br Med J 1979; 1: 722.
- Puri VN. Increased urinary antidiuretic hormone excre-tion by imipramine. Exp Clin Endocrinol 1980; 88: 112–4.
- Lovering JS, Tallet SE, McKendry JBJ. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 1988; 82: 104–6.
- Persson-Jiinemann C, Seemann O, Köhrmann KU, et al. Comparison of urodynamic findings and response to Oxybutynin in nocturnal enuresis. Eur Urol 1993; 24: 92–6.
- Norgaard JP, Pedersen EB, Djurhuus JC. Diurnal anti-diuretic hormone levels in enuretics. J Urol 1985; 134: 1029–31.
- Wille S, Aili M, Harris A, Aronsons S. Plasma and urinary levels of vasopressin in enuretic and non-enuretic children. Scand J Urol Nephrol 1994; 28: 119–22.
- Thero P. Desmopressin in nocturnal enuresis. J Urol 1991; 145: 818–20.
- Miller KM, Goldberg S, Atkin B. Nocturnal enuresis: experience with long term use of intranasally adminis-tered desmopressin. J Pediatr 1989; 114: 723–6.
- Hjalmas K. SWEET, the Swedish Enuresis Trial. Scand J Urol Nephrol 1995; 73 Suppl 1: 89–93.
- Norgaard JP, Pedersen EB, Djurhuus JC. Diurnal antidiuretic hormone levels in enuretics. J Urol 1985; 134: 1029.
- Rifting S, Knudsen UB, Norgaard JP, et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989; 256: F664–71.
- Wille S, Aili M, Harriss A, Aronson S. Plasma and urinary levels of vasopressin in enuretic and non-enuretic children. Scand J Urol Nephrol 1994; 28: 119–22.
- Hall M, Schurmans T, Janssen F. Desmopressin treatment for nocturnal enuresis: which dose and how long? Acta Urol Belgica 1995; 63: 117.
- Frokiaer J, Nelsen S. Do aquaporins have a role in nocturnal enuresis? Scand J Urol Nephrol 1997; 31 Suppl: 31–2.
- Moffatt MEK, Harlos S, Kirshen AJ, Burd L. Desmo-pressin acetate and nocturnal enuresis: How much do we know? Pediatrics 1993; 92: 420–5.
- Evans JHC, Meadow SR. Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response. Arch Dis Child 1992; 67: 184–8.
- Dimson SB. DDAVP and urine osmolality in refractory enuresis. Arch Dis Child 1986; 61: 1104–7.
- Riccabona M, Oswald J, Glauninger P. Long-term use and step-by-step dosage reduction of intranasal desmo-pressin (DDAVP) in the treatment of 155 enuretic children. ICCS, 12–13 June, Paris. (Abstract) 121.